BioSpace News Archive

Addex Therapeutics announced that it will issue its Half-Year 2022 financial results on Thursday, August 18, 2022 and provide a business update and review its pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CEST the same day.

The gadgets utilized in the medical care settings for the reprocessing techniques of the endoscopes are called endoscope reprocessing gadgets.

Cerevel Therapeutics Holdings, Inc. announced the pricing of its previously announced underwritten public offering of 7,250,000 shares of its common stock at a public offering price of $35.00 per share, or approximately $253.8 million of shares of its common stock.

Pfizer Inc. announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate for the prevention of invasive pneumococcal disease caused by the 20 Streptococcus pneumoniae serotypes contained in the vaccine for the pediatric population.

Seegene Inc. (KQ096530), South Korea’s leading molecular diagnostics company, today reported first-half (H1) revenue in 2022 of KRW 579.9 billion (USD 445.8 million), down 11 percent year-over-year. Operating profit fell 37 percent to KRW 212.7 billion.

CASI Pharmaceuticals, Inc. today reported financial results for the second quarter of 2022.

Mannatech, Incorporated today announced financial results for its second quarter of 2022.

GreenLight Biosciences today announced a private placement of approximately $109 million.

Ocugen, Inc announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will deliver a virtual presentation at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17.

A greater focus on preventive healthcare, the need to reduce healthcare costs, more expenditure in digital therapies and increasing prevalence of avoidable chronic illnesses are all likely to drive the growth of the global digital therapeutics market in the near future.